NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

藥用玻璃包裝的世界市場

Pharmaceutical Glass Packaging

出版商 Global Industry Analysts, Inc. 商品編碼 941088
出版日期 內容資訊 英文 377 Pages
商品交期: 最快1-2個工作天內
價格
藥用玻璃包裝的世界市場 Pharmaceutical Glass Packaging
出版日期: 2021年05月01日內容資訊: 英文 377 Pages
簡介
在COVID-19危機中,2020年全球藥用玻璃包裝市場估計為150億美元,在2020-2027年期間的複合年增長率為4.9%,到2027年將增長209%。預計將達到1億美元。

按類型劃分,小瓶行業預計將以5.3%的複合年增長率增長,到分析期結束時達到82億美元。

接受調查的公司示例

  • Arab Pharmaceutical Glass Co.
  • Ardagh Group SA
  • Beatson Clark
  • Bormioli Pharma S.p.a.
  • Corning, Inc.
  • Gerresheimer AG
  • Nipro Corporation
  • Piramal Enterprises Ltd.
  • SCHOTT AG
  • Sgd SA
  • Sisecam Group
  • Stolzle-Oberglas GmbH
  • West Pharmaceutical Services, Inc.

本報告調查了藥用玻璃包裝的市場,定義並概述了市場,分析了影響市場增長的各種因素,市場規模的變化和預測,以及按類別,地區和主要國家/地區劃分的詳細信息。它包括分析,競爭環境,關鍵公司簡介等。

內容

I。簡介,調查方法,調查範圍

II。執行摘要

第1章市場概述

  • 全球競爭對手的市場佔有率
  • 市場佔有率情景:2019年和2025年
  • Covid-19的影響和即將到來的全球衰退

第2章主要公司

第3章市場趨勢和驅動力

第4章世界市場展望

III。市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 意大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV。競爭

  • 公司簡介:44家公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP13956

Abstract:

Global Pharmaceutical Glass Packaging Market to Reach $26.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Pharmaceutical Glass Packaging estimated at US$15.7 Billion in the year 2020, is projected to reach a revised size of US$26.6 Billion by 2027, growing at a CAGR of 7.9% over the analysis period 2020-2027. Bottles, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$8.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vials segment is readjusted to a revised 8.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at 9.2% CAGR

The Pharmaceutical Glass Packaging market in the U.S. is estimated at US$4.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4 Billion by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Ampoules Segment to Record 9.7% CAGR

In the global Ampoules segment, USA, Canada, Japan, China and Europe will drive the 9.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.7 Billion in the year 2020 will reach a projected size of US$5.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027, while Latin America will expand at a 10.3% CAGR through the analysis period.

Select Competitors (Total 41 Featured) -

  • Arab Pharmaceutical Glass Co.
  • Ardagh Group S.A.
  • Beatson Clark
  • Bormioli Rocco SpA
  • Corning, Inc.
  • Gerresheimer AG
  • Nipro Corporation
  • Piramal Glass
  • SCHOTT Pharmaceutical Packaging
  • SGD Pharma
  • Shandong Qidu Pharmaceutical Co., Ltd.
  • Sisecam Group
  • Stevanato Group S.p.A.
  • Stolzle-Oberglas Gmbh
  • West Pharmaceutical Services, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • COVID-19 Impact on Pharmaceutical Packaging Market
    • EXHIBIT 1: Growing COVID-19 Cases and Efforts to Develop Vaccines Presents Opportunity for Pharmaceutical Glass Packaging Market: Top Countries Ranked by Number of COVID-19 Cases
    • COVID-19 to Restructure the Pharmaceutical Supply Chain Management
    • Pharmaceutical Companies Devise Innovative Strategies for Streamlining Supply Chain Networks
    • Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand for Glass Packaging
    • EXHIBIT 2: COVID-19 Vaccines in Pipeline by Technology and Clinical Stage
    • Efforts to Boost Manufacturing of Glass Vials and Prefilled Syringes for COVID-19 Vaccine Gain Traction
    • Fears of Glass Vial Shortage Prompts Flurry of Industry Activities
    • Glass Packaging: Sustainable, Green, and Pure Form of Packaging
    • An Introduction to Pharmaceutical Glass Packaging
    • Types of Glass Containers Used for Packaging in Pharmaceutical Industry
    • Pharmaceutical Glass Packaging Product Types
    • Key Advantages & Disadvantages of Glass Containers
    • Global Market Prospects & Outlook
    • Glass Bottles: The Largest Product Type
    • Generic Drugs Represent the Largest Segment
    • Developed Regions Lead the Pharmaceutical Glass Packaging Market
    • Growth of Pharmaceutical Manufacturing in Developing Economies Supports Market
    • Competition
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
    • EXHIBIT 3: Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Rapid Growth of Generic Drugs Augurs Well for Glass Packaging Market
    • EXHIBIT 4: Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
    • Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques
    • EXHIBIT 5: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
    • Aging Population, Increasing Burden of Chronic Disease and Consequent Rise in Demand for Injectables Drugs Augurs Well for Glass Packaging
    • EXHIBIT 6: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 7: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 8: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Contract Packaging Trend Augurs Well for the Pharma Glass Packaging Market
    • Ampoules Emerge as a Preferred Packaging Option for Pharma Companies
    • Parenteral Packaging Market Drives Demand for Glass Vials & Ampoules
    • EXHIBIT 9: Parenteral Packaging Market by Product (in %) for 2020E
    • Silica Bottles Facilitate Targeted Drug Delivery
    • Innovative Glass Packaging Solutions Help Improve Quality of Drugs
    • Innovations & Advancements Drive Market Growth
    • SCHOTT Offers syriQ BioPure® and SCHOTT TOPPAC® Syringes
    • Corning Creates Boron-Free Valor® Glass
    • Recyclability and Sustainability Increases Commodity Value of Glass, Paving Way for Use in Pharma Sector
    • Impending Phase-out of Plastic Brings to Light the Importance of Glass for Pharmaceutical Packaging Companies
    • Glass Flakes: A Key Concern for the Pharmaceutical Glass Packaging Manufacturers
    • Aluminosilicate Glass Emerges as a Solution to the Issue of Glass Flakes
    • Product Recall Incidents Likely to Hamper Market Stability
    • Alternative Materials Present A Threat to Glass Packaging in Pharmaceutical Industry
    • EXHIBIT 10: Global Pharmaceutical Packaging Market by Material (in %): 2020E
    • High Cost of Glass Packaging Containers: A Major Market Restraint
    • EXHIBIT 11: Cost Breakdown for Container Glass by Components
    • Emphasis on Product Integrity Drives Need for Anti-Counterfeit Pharmaceutical Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Bottles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ampoules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Cartridges & Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Branded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Biologic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Packaging Market in the US: An Overview
    • EXHIBIT 12: US Pharmaceutical Packaging Market by Material (in %) for 2020E
    • TABLE 25: USA Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • CHINA
    • Market Overview
    • TABLE 43: China Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • EUROPE
    • Europe Pharmaceutical Packaging: A Prelude
    • EXHIBIT 13: Europe Pharmaceutical Packaging Materials Market by Application (in %) for 2020E
    • TABLE 49: Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 82: Spain Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Spain Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Spain 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 85: Spain Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 88: Russia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Russia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Russia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 91: Russia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Market Overview
    • Asia-Pacific to Witness Introduction of New Syringes and Ampoules
    • TABLE 100: Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 101: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 109: Australia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Australia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Australia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 112: Australia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • INDIA
    • Indian Glass Vial Manufacturers Prepare for Demand Surge for Bottling COVID-19 Vaccines
    • Changing Product Portfolio Composition Drives Spending on Packaging
    • TABLE 115: India Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: India Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: India 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 118: India Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 121: South Korea Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: South Korea Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: South Korea 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 124: South Korea Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • Vials and Ampoules to Witness Robust Demand in Latin America
    • TABLE 133: Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 142: Argentina Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Argentina Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Argentina 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 145: Argentina Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 148: Brazil Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Brazil Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Brazil 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 151: Brazil Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 154: Mexico Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Mexico Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Mexico 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 157: Mexico Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 163: Rest of Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 166: Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 167: Middle East Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 175: Iran Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Iran Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Iran 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 178: Iran Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 181: Israel Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Israel Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Israel 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 184: Israel Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 187: Saudi Arabia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Saudi Arabia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 190: Saudi Arabia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 193: UAE Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: UAE Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: UAE 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 196: UAE Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 199: Rest of Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Rest of Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 202: Rest of Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 205: Africa Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Africa Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Africa 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
    • TABLE 208: Africa Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41